Feb 15 2010

Home >> Clinical Trials News Archive >> 2010 >> Feb 15 2010

The U.S. Food and Drug Administration (FDA) recently released draft guidance for institutional review board (IRB) continuing review—the first updates that the regulatory agency has provided for this process since it issued IRB regulations in 1981. 

Seminar: How to approach medical consumers: Insights for research, development, and marketing experts. March 9, 2010.

Visit Q-Trials at the ILSI-Biomed 2010 Conference
to be held June 14-16, 2010 in Tel-Aviv.